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ARTICLE OPEN
Hospital readmissions for COPD: a retrospective longitudinal
study
Timothy H. Harries1, Hannah Thornton2, Siobhan Crichton1, Peter Schoﬁeld1, Alexander Gilkes1 and Patrick T. White1
Prevention of chronic obstructive pulmonary disease hospital readmissions is an international priority aimed to slow disease
progression and limit costs. Evidence of the risk of readmission and of interventions that might prevent it is lacking. We aimed to
determine readmission risk for chronic obstructive pulmonary disease, factors inﬂuencing that risk, and variation in readmission risk
between hospitals across 7.5 million people in London. This retrospective longitudinal observational study included all chronic
obstructive pulmonary disease admissions to any hospital in the United Kingdom among patients registered at London general
practices who had emergency National Health Service chronic obstructive pulmonary disease hospital admissions between April
2006 and March 2010. Inﬂuence of patient characteristics, geographical deprivation score, length of stay, day of week of admission
or of discharge, and admitting hospital, were assessed using multiple logistic regression. 38,894 chronic obstructive pulmonary
disease admissions of 20,932 patients aged≥ 45 years registered with London general practices were recorded. 6295 patients
(32.2%) had at least one chronic obstructive pulmonary disease readmission within 1 year. 1993 patients (10.2%) were readmitted
within 30 days and 3471 patients (17.8%) were readmitted within 90 days. Age and patient geographical deprivation score were
very weak predictors of readmission. Rates of chronic obstructive pulmonary disease readmissions within 30 days and within
90 days did not vary among the majority of hospitals. The ﬁnding of lower chronic obstructive pulmonary disease readmission rates
than was previously estimated and the limited variation in these rates between hospitals suggests that the opportunity to reduce
chronic obstructive pulmonary disease readmission risk is small.
npj Primary Care Respiratory Medicine  (2017) 27:31 ; doi:10.1038/s41533-017-0028-8
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a leading cause
of emergency hospital medical admissions and readmissions
worldwide.1, 2 Preventing COPD readmissions following an
exacerbation has been identiﬁed as an international priority to
limit the physical deterioration of patients and to contain costs.3, 4
In an effort to curb hospital readmissions health service payments
to United Kingdom (UK) National Health Service (NHS) hospitals
for patients readmitted within 30 days of discharge have been
restricted since 2011 under the Payment by Results scheme.5, 6
This is especially the case for those readmissions judged to be
avoidable. In COPD the rate of readmissions within 30 days has
been used as a marker of quality of care within the NHS.7 COPD is
an ambulatory care sensitive condition (ACSC) for which it is
considered that hospital admission may be avoided by effective
interventions in primary or preventative care.8 Reductions of
up to 18% in emergency admissions for ACSCs have been
estimated to be achievable.9 ACSCs were included as an outcome
indicator upon which NHS hospital reimbursement was based as
recently as 2014–2015.10 The reliability of this measure is
doubtful as the true proportion of avoidable readmissions is not
known.11 Evidence is lacking on the effectiveness of case-based
interventions in reducing admission risk.12 Smoking is a known risk
factor for the development of COPD and is a predictor of COPD
exacerbations.13, 14
The rate of emergency admissions within the NHS in England
between 2000 and 2012 increased by 27%, coinciding with
approximately a 24% decrease in general and acute hospital bed
numbers over the same period.15 The all-cause 30-day read-
mission rate within the NHS in England between 2004 and 2010
was 7.0% with a gradual increase of 0.01% per month.16 A meta-
analysis of international studies identiﬁed that fewer than one in
four 30-day readmissions was likely to have been preventable.17
Patient level factors have been identiﬁed as determinants of
COPD readmission risk. These include a history of previous
hospital admission, poor performance status of the patient, COPD
disease severity, number of comorbidities, lower reported health
status and quality of life score and dyspnoea on admission.18–21
The inﬂuence of service level predictors on the risk of COPD
hospital admission and readmission is unclear. Within the NHS the
rate of COPD admissions remained stable between 2001 and
2010,22 and variation in primary care services for COPD has not
been shown to be associated with risk of COPD admission.23
A series of inﬂuential audits of COPD hospital care by the UK Royal
College of Physicians (RCP) found that hospital resource and
organisational factors were not associated with the rate of COPD
readmissions and did not account for variation in COPD read-
mission risk between hospitals.24 No association was found
between type of admitting physician, hospital admissions policy,
size of hospital respiratory unit, use of an early discharge scheme,
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length of hospital stay or presence of pneumonia and risk of COPD
readmission.25–27
COPD readmission rates vary between countries. Within the UK
the RCP audits recorded 90-day COPD readmission rates of
31–35%.19, 24, 28, 29 In other parts of the world 30-day readmission
rate is the more commonly used outcome measure. 30-day
COPD readmission rates within the US have been reported to
be as low as 5.6% and as high as 20%.30–32 Observational
data from New Zealand found a 30-day COPD readmission rate of
6.7%.33
The extent to which COPD readmissions can be prevented is
unknown. In treatment naïve patients there is good evidence for
the effectiveness of medications in reducing exacerbation
and admission risk.34 In the UK, the adoption of active pres-
cribing of medications for COPD has been so great that
there is now widespread over-prescribing of high dose inhaled
corticosteroids in combination with long-acting inhaled
beta-agonists.35 Although studies of the effect of post-discharge
care schemes suggest that COPD readmission risk may be
modiﬁable,34, 36, 37 these are tempered by contradictory
ﬁndings from other initiatives that have been unsuccessful in
reducing COPD readmissions.38, 39 Despite efforts to reduce
the number of admissions, total hospitalisations and emer-
gency department visits for COPD have not decreased over
the past decade.40 Evidence of variation in readmission risk
between hospitals may provide an opportunity for hospital
managers and those commissioning services to improve the
quality of care of COPD patients in hospitals with higher
readmission risk.
This study aimed to describe the readmission risk of COPD
hospital admission of all patients registered at all London general
practices between 2006 and 2010. It sought to determine
predictors of COPD readmission and the variation in risk of COPD
readmission between different hospitals.
RESULTS
COPD admissions (38,894) from 20,932 patients aged≥ 45 years
registered with general practices in London were recorded
between 1st April 2006 and 31st March 2010. These 20,932
patients each had an index COPD admission between 1st April
2006 and 31st March 2009.
Among the index COPD admissions 15,907 (76%) occurred on a
weekday and 5025 (24%) at the weekend. 18,449 (88.1%)
discharges occurred on a weekday and 2483 (11.9%) at the
weekend. 2257 (10.8%) patients were admitted for <1 day. Index
admissions had a mean (SD) length of stay (LOS) of 7.8 (11.3) days.
Median (IQR) LOS was 5 (2–9) days. 1381 (6.6%) patients died
during the index admission. 19,551 patients were at risk of
readmission in the subsequent year. The outcome of admission
was not available for 2% of patients.
Patients who were readmitted with COPD within 1 year (6295)
were slightly more deprived and a slightly higher proportion of
them were male than those patients who were not readmitted
with COPD within 1 year (13,256) (Table 1).
Risk of COPD readmission
6295 patients (32.2%) had at least one COPD readmission within
1 year. In their ﬁrst COPD readmission 164 patients (0.8%) were
readmitted on the same day, 1993 patients (10.2%) were
readmitted within 30 days, 3471 patients (17.8%) were readmitted
within 90 days and 4698 patients (24.0%) were readmitted within
182 days.
Patient factors associated with COPD readmission
Very weak correlations were found between patient age and risk
of COPD readmission within 30 days (r = 0.034, p < 0.0001) and
between patient age and risk of COPD readmission within 90 days
(r = 0.032, p < 0.0001). Very weak correlations were found between
patient Index of Multiple Deprivation (IMD) score and risk of COPD
readmission within 30 days (r = 0.017, p = 0.015) and between
patient IMD score and risk of COPD readmission within 90 days
(r = 0.028, p < 0.0001).
Inﬂuence of LOS on COPD readmission risk
Patients whose index COPD admission had a LOS of 3–5 days had
a lower risk of COPD readmission within 30 days compared to
patients whose index COPD admission lasted for 2 days or less
(Table 2). Patients whose index COPD admission had a LOS of
greater than 9 days had a greater risk of COPD readmission within
90 days compared to those patients whose index COPD admission
lasted for 2 days or less.
Inﬂuence of day of the week of admission and discharge on COPD
readmission risk
Risk of COPD readmission within 30 days and within 90 days was
unaffected either by the day of the week on which the index
COPD admission had occurred or by the day of the week on which
the patient was discharged from their index COPD admission.
Analysis of COPD readmission rate by hospital
The mean COPD readmission rate within 30 days to any hospital,
among those hospitals which had received index COPD admissions,
varied between 5.8% (95% CI: 1.3 to 10.2) and 12.7% (95% CI: 10.5 to
15.0) after adjustment for patient age, sex and the effect of
clustering of patients within hospitals (Fig. 1). The mean COPD
readmission rate within 90 days to any hospital, among those
hospitals which had received index COPD admissions, varied
between 13.3% (95% CI: 10.1 to 16.6) and 22.3% (95% CI: 18.2 to
26.4) after adjustment for patient age, sex and the effect of
clustering of patients within hospitals (Fig. 2). Hospitals were ordered
in Figs 1 and 2 by ascending COPD readmission rate within 30 days.
Sensitivity analysis
A sensitivity analysis was carried out to assess the potential impact
of deaths in the community after discharge on risk of readmission
for COPD. An adjusted COPD readmission rate within 90 days was
calculated using an estimated 90-day mortality rate in the
community of 25%. Twenty-ﬁve percent of 16,080 patients (those
not readmitted within 90 days) represented 4020 additional
patients who would have been at risk of readmission but who
may not have been readmitted due to death unknown to the study.
Table 1. Comparison between patients who were readmitted with
COPD within 1 year (6295) of the index COPD admission and those
patients who were not readmitted within 1 year (13,256), 2006–2010
Patient characteristic Mean (SD) Difference between
means (±95% CI)
Patient age Readmitted 72.5 (10.3) 0.2 (−0.17 to 0.48)
(years) Not readmitted 72.3 (11.1)
Deprivation Readmitted 29.2 (13.1) 1.2 (0.89 to 1.68)
score (IMD) Not readmitted 28.0 (13.3)
Males (%) Readmitted 53.6
Not readmitted 51.5
CI conﬁdence interval, IMD index of multiple deprivation, SD standard
deviation, df degrees of freedom
Difference between proportion of males (%): χ2(1)= 8.15, p= 0.004
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The current study’s COPD readmission rate within 90 days of 17.8%
was applied to these 4020 additional patients, which would
have provided an additional 716 COPD readmissions within 90 days.
The adjusted total number of patients readmitted with COPD
within 90 days in this sensitivity analysis was 716 + 3471 = 4187
patients. The adjusted COPD readmission rate within 90 days
was 21.4%.
DISCUSSION
Main ﬁndings
Of 20,932 patients in London (population 7.5 million) admitted to
hospital with COPD 32% (6295) were readmitted within one year
between 2006 and 2010. Ten percent were readmitted within
30 days and 18% within 90 days. Rates of COPD readmissions
within 30 days and within 90 days did not vary among the
Table 2. Comparison of the risk (odds ratio± 95% CI) of COPD readmission within 30 days and 90 days, dependent on the LOS of the index COPD
admission. Multiple logistic regression adjusted for patient sex, age, and deprivation score
Readmission rate within 30 days Readmission rate within 90 days
LOS≤ 2 days (Reference) 10.4% 16.6%
LOS 3–5 days 9.4% OR: 0.87 (0.77–0.99) 17.6% OR: 1.06 (0.96–1.17)
LOS 6–9 days 9.9% OR: 0.93 (0.82–1.07) 18.1% OR: 1.09 (0.98–1.22)
LOS> 9 days 11.1% OR: 1.03 (0.91–1.17) 19.3% OR: 1.17 (1.05–1.30)
Fig. 1 COPD readmission rates to hospitals within 30 days. Readmission rates (±95% CI) within 30 days of all COPD patients admitted (18,848)
to included English hospitals between 2006 and 2010, shown in ascending order and adjusted for clustering, age and sex of patients
Fig. 2 COPD readmission rates to hospitals within 90 days. Readmission rates (±95% CI) within 90 days of all COPD patients admitted (18,848)
to included English hospitals between 2006 and 2010, and adjusted for clustering, age and sex of patients
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majority of hospitals. Age and patient geographical deprivation
score (IMD) were very weak predictors of readmission within
30 days or within 90 days. Adjustment for out-of-hospital
mortality, or for day of the week of admission to or discharge
from hospital did not inﬂuence readmission risk.
Interpretation of ﬁndings in relation to previously published work
The low rates of COPD readmission within 30 days and within
90 days suggest that interventions designed to reduce the risk of
COPD readmission have a small opportunity for improvement.
There is no indication as to which patients might beneﬁt from
such an intervention. Among COPD patients receiving recom-
mended pharmacological treatment there is limited evidence that
additional interventions inﬂuence the risk of readmission.34 This is
supported by the limited variation in the rate of COPD read-
missions among the majority of hospitals in the current study. The
variation in readmission rates between hospitals is in keeping with
national emergency admissions data from 150 English NHS
hospitals.41 These data showed little variation in admission rates
between the majority (80%) of hospitals. Previous work, con-
temporary with the current study, has reported high levels of
overtreatment of patients with COPD in London.35 It is likely that
patients in the current study of COPD readmissions were receiving
similar treatment to that reported in London at the same time.
The difference we observed in the risk of readmission within
30 days between patients whose LOS was 3–5 days compared to
those whose LOS was ≤2 days was statistically signiﬁcant but we
doubt its clinical importance since the percentage difference
between the groups was only 1%. We feel the same argument
holds true regarding the difference observed in the risk of
readmission within 90 days.
The COPD readmission rates reported in this study were in
keeping with international ﬁndings.30–33 They were approximately
half those reported by the RCP’s national audits of COPD care
between 1997 and 2015.29 The accuracy and representativeness of
the RCP audits’ reports of COPD readmissions have been
questioned in this journal.42 In the RCP audits patients admitted
to hospital with COPD were identiﬁed prospectively but had to
have a known diagnosis of COPD at the point of admission.29
Patients in whom the diagnosis of COPD was not known at
admission, even if that diagnosis was corrected to COPD
subsequently during the admission were excluded. This method
risked skewing enrolment towards those patients at the most
severe end of the COPD spectrum. In addition, it is unlikely that
those patients admitted for <1 day would have been included in
the audits due to the practicalities of recruitment.
In contrast the study reported here provided a comprehensive
picture of COPD admissions from a representative UK population.
It included all admissions and readmissions from all COPD patients
registered at London general practices, including readmissions to
hospitals which were not the initial admitting hospital. As a result,
the readmission rate in this study would have been predicted to
be even higher than that of the RCP audits. This was not the case.
Previous work which examined the LOS of COPD patients during
their index admission to hospital, found that the mean interval
between the index admission and ﬁrst readmission was just under
400 days,43 a ﬁgure in keeping with the readmission rates
reported here.
Strengths and limitations of this study
The main strength of this study lies in the comprehensiveness of
the data included. All NHS COPD admissions of patients registered
at London general practices to all hospitals in England were
included. This represents a population of at least 7.5 million
people in which more than 97% were registered with general
practices. The data relate to four consecutive years within a period
in which we have previously demonstrated stable national rates of
admission for COPD.22
Our data were complete for the population of London. They
are unlikely to be representative of the whole of England.
The recorded prevalence of COPD in London at the time of this
study was 1.1% compared to 1.7% nationally so it may be that the
risk of COPD is lower in London.35 Risk of admission for COPD in
London is similar to the average risk nationally.44 Similarities
between our data and those reported in New Zealand and the
United States of America suggest our data reﬂect a risk of
readmission for COPD in keeping with the disease in several
different environments. Data were not available on a number of
patient characteristics that may be related to risk of admission
including COPD severity, patient performance status, socio-
economic deprivation, treatment (pharmacological and non-
pharmacological) received, and comorbidities.
Implications for future research, policy and practice
This paper offers important implications for future policy, practice,
and research in the management of COPD. The opportunity for
intervening to prevent COPD readmissions is likely to be less than
was previously thought because of the lower than expected rates
of readmission of COPD we have found. We have shown that
patients at risk of readmission cannot easily be identiﬁed using
routinely available demographic data or differences in LOS or
other medical care data. There is limited variation in the risk of
COPD readmission between hospitals. This should discourage
reliance on COPD readmission risk as a marker of quality of care.
There is a need for better understanding of the role of disease
severity in the risk of admission for COPD. Finally, a prospective
study should be carried out to assess the impact of smoking
cessation on preventing hospital admission and readmission in
patients with established COPD who have moderate to very
severe COPD.
CONCLUSIONS
This study has provided new insights into the distribution of
readmissions among patients admitted to NHS hospitals with COPD
exacerbations. The ﬁnding of lower rates of COPD readmission than
was previously estimated and the limited variation between
hospitals calls into question the value of COPD readmission rate
as a marker of quality of care. The potential savings resulting from
improvements in COPD readmission rates, if they could be
achieved, may not justify the cost of initiatives aimed at cutting
those readmissions. Hospital level factors have not been demon-
strated to be key determinants of COPD readmission. This suggests
that patient level factors including disease severity may have a
greater role in inﬂuencing readmissions for COPD. It emphasises the
need to direct efforts towards smoking cessation in the primary and
secondary prevention of COPD if we are to reduce the admissions
and readmissions caused by it.
METHODS
Study setting
London, the setting of this study, has an ethnically and socioeconomically
diverse population of approximately 7.5 million people.45
Study design and data source
This was a retrospective longitudinal observational study of all COPD
patients registered at London general practices who had emergency NHS
COPD hospital admissions between 1 April 2006 and 31 March 2010. The
NHS Information Centre provided routinely collected data from the Hospital
Episodes Statistics (HES) dataset, an inclusive record of NHS hospital activity
within England.46, 47 HES track every hospital admission in the NHS
providing publicly accessible data. Each HES record contained anonymised
Hospital readmissions for COPD
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(but uniquely identiﬁed) information relating to an emergency hospital
admission including patient demographics, Index of Multiple Deprivation
(IMD) score for the patient’s address and registered general practitioner,
diagnostic and procedural codes, admitting hospital, admission and
discharge dates, discharge destination and LOS. IMD is a multi-
dimensional score based on decennial national census data and annual
local authority population data reﬂecting socio-economic deprivation within
a geographical area based on the residential address of the patient.48 The
diagnosis ﬁeld was set to identify all patient admissions with a primary
diagnosis of COPD (ICD-10 codes J40-J44) for the ﬁrst episode within the
hospital admission spell (the whole admission) between 2006 and 2010.
Patient and hospital inclusion criteria
Analysis of COPD readmission rate was carried out for all patients who
underwent an NHS COPD admission between 1 April 2006 and 31 March
2009 and who were aged ≥45 years at the time of that admission.
Admission history prior to 1 April 2006 was not included in the analysis.
The exclusion of younger patients was consistent with the criteria used in
clinical trials of treatments for COPD.49 Younger patients may differ from
older patients with COPD in their disease pathology and natural history.50
The majority of COPD patients are over 45 years. The cut off of 31 March
2009 for index cases was set so that any admissions in the subsequent
year, up to and including 31 March 2010, of each patient so identiﬁed
would be included in the data set.
NHS hospitals were identiﬁed by their provider codes and were included
in the analysis if they had a record of ≥100 COPD patient admissions
during the study period. This criterion was applied to allow a comparison
of hospitals which had responsibility for emergency admissions whose
medical care might have expected to include COPD. Hospitals specialising
in operative procedures for COPD including bronchial stenting, bullectomy,
lung volume reduction and transplantation were excluded. If two or more
hospitals had merged during the study period, the admissions from each
of the hospitals were combined. These mergers usually occurred between
neighbouring hospitals. This meant that patients within the catchment
areas of the two hospitals would have had a similar likelihood of being
admitted to either hospital.
Statistical analysis
Descriptive analysis. Descriptive analysis of the index COPD admissions
was undertaken. This included analysis of the proportion of patients
admitted and discharged on a weekday, the proportion of patients
admitted for <1 day and a description of the LOS of the index COPD
admissions. Weekday was deﬁned as Monday to Friday, and weekend as
Saturday or Sunday.
A comparison was made of the age, sex, and deprivation scores of
patients readmitted with COPD within 1 year of the index COPD admission
and those patients who were not readmitted within 1 year. The differences
between the groups were analysed using the Chi-squared test and the
independent samples t-test.
To examine the COPD readmission rate to hospital within 1 year of the
index COPD admission, the proportion of patients readmitted on the same
day, within 30 days, within 90 days, within 182 days and within 1 year
among patients aged ≥45 years was calculated.
Sensitivity analysis of COPD readmission rate. The risk of death in the
community among patients discharged after an admission for COPD was
unknown. Those patients who died in the community would have been
removed from the pool of patients at risk of readmission. A sensitivity
analysis was performed to allow for the effect of unknown deaths among
discharged patients after their index admission for COPD. An estimate of
the proportion of deaths in the community was made using Ofﬁce for
National Statistics (ONS) rates of death in 2008, the midpoint of the
study.51 The risk of readmission was recalculated on the assumption that
these deaths had not occurred. The death rate within 90 days of admission
for COPD has been recorded as between 13–17%.52 The 2008 ONS
mortality ﬁgures listed annual death rates for patients aged 90 years and
over as 241.3/1000 population (males) and 225.3/1000 population
(females).51 For the current study an estimated 90-day mortality rate in
the community of 25% was chosen. This was considered as a “worst-case
scenario”. An adjusted COPD readmission rate within 90 days was
calculated as an example.
Determinants of COPD readmission risk. To determine the inﬂuence that
patient characteristics had on COPD readmission risk, two-tailed partial
correlations were sought between mean patient age and mean patient
IMD score per admission and the percentage of patients readmitted with
COPD within 30 days and the percentage of patients readmitted with
COPD within 90 days.
To determine the inﬂuence that LOS of index COPD admission had on
the risk of readmission with COPD within 30 days and within 90 days,
multiple logistic regressions were undertaken, controlling for patient sex,
age, and deprivation score. LOS of each index COPD admission was
grouped by quartile.
The inﬂuence on the risk of readmission with COPD within 30 days and
the risk of readmission within 90 days of the day of the week on which the
index COPD admission began and the day of the week on which it ended
was determined. Chi-squared tests were performed to compare the risk of
readmission if the index COPD admission had occurred on a weekday
compared to at the weekend and to compare the risk of readmission if the
discharge from the index COPD admission had occurred on a weekday
compared to at the weekend.
To examine the inﬂuence that the hospital to which patients were
admitted during their index COPD admission had on the risk of
readmission with COPD to any hospital, the proportion of patients who
had a COPD readmission within 30 days and within 90 days was compared
between the 29 included hospitals, following adjustment for patient age,
sex and the effect of clustering of patients within hospitals. A ﬁxed effects
model was used with each hospital entered as a separate term in the
multiple logistic regression model as well as the above confounders.
Hospitals were anonymised in the results.
The statistical packages SPSS version 20 (IBM Corporation, New York)
and STATA version 13 were used for data analysis. Ethics approval was not
required for this study which used routinely collected anonymised data to
inform delivery of care.
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